I’m going to vote no based on the very limited scope in summary. Does this only apply to opioid? Or does the set a precedent for preemptively striking out medical marijuana growers and distributors? I feel like this legislation would illegitimately expand the bureaucratic authority of the DEA to bar licenses without proper review and authority to do so. It sounds like legislation big pharma would lobby for to usurp the ability for smaller distributors to be banned from competition. I’d need to read this in full to have a comprehensive understanding of the scope of authority here and whether it would be an overreach of government or not.